These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9145299)

  • 21. Pharmacological characterisation of CR6086, a potent prostaglandin E
    Caselli G; Bonazzi A; Lanza M; Ferrari F; Maggioni D; Ferioli C; Giambelli R; Comi E; Zerbi S; Perrella M; Letari O; Di Luccio E; Colovic M; Persiani S; Zanelli T; Mennuni L; Piepoli T; Rovati LC
    Arthritis Res Ther; 2018 Mar; 20(1):39. PubMed ID: 29490676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type II collagen induced arthritis in rats: clinical and immunological studies.
    Kerwar SS; Oronsky AL
    Int J Tissue React; 1985; 7(6):409-29. PubMed ID: 2935508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
    Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
    BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histopathological study of arthritic lesions induced by immunization with type II collagen in DBA/1J mouse].
    Imaizumi K; Hinoue H; Ueno M; Takata I; Sato T; Minato Y; Takeshita M; Okaniwa A
    Jikken Dobutsu; 1990 Jan; 39(1):27-34. PubMed ID: 2303092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis.
    Goodfellow RM; Williams AS; Levin JL; Williams BD; Morgan BP
    Clin Exp Immunol; 2000 Jan; 119(1):210-6. PubMed ID: 10606985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
    Bendele AM; Benslay DN; Hom JT; Spaethe SM; Ruterbories KJ; Lindstrom TD; Lee SJ; Naismith RW
    J Pharmacol Exp Ther; 1992 Jan; 260(1):300-5. PubMed ID: 1309875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models of arthritis: relevance to human disease.
    Bendele A; McComb J; Gould T; McAbee T; Sennello G; Chlipala E; Guy M
    Toxicol Pathol; 1999; 27(1):134-42. PubMed ID: 10367688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in focal adhesion kinase expression in rats with collagen-induced arthritis and efficacy of intervention with disease modifying anti-rheumatic drugs alone or in combination.
    Gao HY; Luo J; Li XF; Lv Q; Wen HY; Song QZ; Zhao WP; Zhao XC; Zhang TT; Zhang SY; Zhi JM
    Int J Clin Exp Pathol; 2015; 8(12):15573-81. PubMed ID: 26884826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels.
    Kuwabara K; Shudo K; Hori Y
    FEBS Lett; 1996 Jan; 378(2):153-6. PubMed ID: 8549823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
    Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
    Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iridoid glycosides from the flowers of Gentiana macrophylla Pall. ameliorate collagen-induced arthritis in rats.
    Jia N; Chu W; Li Y; Ding L; Duan J; Cui J; Cao S; Zhao C; Wu Y; Wen A
    J Ethnopharmacol; 2016 Aug; 189():1-9. PubMed ID: 27180880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models of collagen-induced arthritis.
    Wagner S; Bindler J; Andriambeloson E
    Curr Protoc Pharmacol; 2008 Dec; Chapter 5():Unit 5.51. PubMed ID: 22294231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis.
    Earp JC; Dubois DC; Molano DS; Pyszczynski NA; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2008 Aug; 326(2):546-54. PubMed ID: 18448864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
    Probert AW; Schrier DJ; Gilbertsen RB
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on type II collagen induced arthritis in rats: an experimental model of peripheral and axial ossifying enthesopathy.
    Gillet P; Bannwarth B; Charrière G; Leroux P; Fener P; Netter P; Hartmann DJ; Péré P; Gaucher A
    J Rheumatol; 1989 Jun; 16(6):721-8. PubMed ID: 2506344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of enzyme therapy and combination therapy with cyclosporin A on collagen-induced arthritis.
    Rovenská E; Svík K; Stancíková M; Rovenský J
    Clin Exp Rheumatol; 2001; 19(3):303-9. PubMed ID: 11407084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin exerts a potent anti-arthritic effect and insulin resistance in collagen-induced arthritic rats.
    Wu D; Hua B; Fang Z; Liu J; Liu N; Ma Y
    Int J Rheum Dis; 2018 Aug; 21(8):1496-1503. PubMed ID: 28752573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis.
    Boyle DL; Kim HR; Topolewski K; Bartok B; Firestein GS
    J Pharmacol Exp Ther; 2014 Feb; 348(2):271-80. PubMed ID: 24244039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.